A Drug Enforcement Administration decide has cancelled a hearing to evaluate the Biden administration’s proposal to reclassify cannabis underneath federal drug legislation amid allegations that officials at the agency have conferred with witnesses against the approach.“AYR applauds right now’s announcement with regards to ongoing development